Product Number |
OAAB04257 |
Product Page |
www.avivasysbio.com/parg-antibody-c-terminal-region-oaab04257.html |
Name |
PARG Antibody - C-terminal region (OAAB04257) |
Molecular Weight |
111110 Da |
Isotype |
Rabbit Ig |
NCBI Gene Id |
8505 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
Approximately 0.5mg/ml. Actual concentration varies with each lot. |
Alias Symbols |
PARG99 |
Product Format |
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. |
Reconstitution and Storage |
Maintain refrigerated at 2-8C for up to 2 weeks. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-PARG antibody - OAAB04257 |
Application Info |
WB: 1:1000 IHC-P: 1:10~50 |
Immunogen |
This Parg antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 390-421 amino acids from the C-terminal region of human Parg. |
Uniprot ID |
Q86W56 |
Protein Name |
Poly(ADP-ribose) glycohydrolase |
Sample Type Confirmation |
PARG is strongly supported by BioGPS gene expression data to be expressed in HEK293 |
Protein Accession # |
NP_003622.2 |
Gene Symbol |
PARG |
Predicted Species Reactivity |
Human |
Application |
WB, IHC |
Predicted Homology Based on Immunogen Sequence |
Human |
Image 1 | 293
| Western blot analysis of Parg Antibody (C-term) in 293 cell lysates (35ug/lane). Parg (arrow) was detected using the purified Pab (1:60 dilution). PARG is strongly supported by BioGPS gene expression data to be expressed in HEK293 |
| Image 2 | Parg
| Western blot analysis of Parg (arrow) using rabbit polyclonal Parg Antibody (C-term) either nontransfected (Lane 1) or lysates transiently transfected transfected with the Parg gene (Lane 2) (Origene Technologies). |
| Image 3 | human brain carcinoma
| Formalin-fixed and paraffin-embedded human breast carcinoma tissue reacted with Parg antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. |
|
|